resorcinol has been researched along with Urinary Bladder Neoplasms in 2 studies
resorcinol: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7951
resorcinol : A benzenediol that is benzene dihydroxylated at positions 1 and 3.
Urinary Bladder Neoplasms: Tumors or cancer of the URINARY BLADDER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurata, Y | 1 |
| Fukushima, S | 1 |
| Hasegawa, R | 2 |
| Hirose, M | 2 |
| Shibata, M | 1 |
| Shirai, T | 1 |
| Ito, N | 2 |
| Furukawa, F | 1 |
| Toyoda, K | 1 |
| Takahashi, M | 1 |
| Hayashi, Y | 1 |
2 other studies available for resorcinol and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Structure-activity relations in promotion of rat urinary bladder carcinogenesis by phenolic antioxidants.
Topics: Animals; Body Weight; Butylated Hydroxytoluene; Carcinogenicity Tests; Catechols; Hydroquinones; Mal | 1990 |
Inhibitory effects of antioxidants on N-bis(2-hydroxypropyl)nitrosamine-induced lung carcinogenesis in rats.
Topics: Adenoma; Animals; Antioxidants; Ascorbic Acid; Body Weight; Butylated Hydroxyanisole; Butylated Hydr | 1990 |